Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving CAR T-Cell Persistence
Violena Pietrobon, Lauren A. Todd, Anghsumala Goswami, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10828-10828
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
CAR T therapies in multiple myeloma: unleashing the future
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 667-686
Open Access | Times Cited: 49
Recent Advances in CAR-Based Solid Tumor Immunotherapy
Min Hwa Shin, Eunha Oh, Yun Jeong Kim, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1606-1606
Open Access | Times Cited: 44
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 31
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 18
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021
Lele Miao, Juan Zhang, Zhengchao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 36
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma
Valerie Wittibschlager, Ulrike Bacher, Katja Seipel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5688-5688
Open Access | Times Cited: 36
Bright future or blind alley? CAR-T cell therapy for solid tumors
Kai Zhang, Hong Chen, Fuqiang Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, et al.
Cells (2024) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells
Mayra A. Carrillo, Anjie Zhen, Wenli Mu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1000-1015
Open Access | Times Cited: 11
Implantable CAR T cell factories enhance solid tumor treatment
Sharda Pandit, Pritha Agarwalla, Feifei Song, et al.
Biomaterials (2024) Vol. 308, pp. 122580-122580
Closed Access | Times Cited: 9
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Torsten Schroeder, Tjark Martens, Lars Fransecky, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 9, pp. 1459-1469
Open Access | Times Cited: 9
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Xiaoxia Chi, Shahang Luo, Peng Ye, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies
Yugu Zhang, Diyuan Qin, Arthur Shou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6124-6124
Open Access | Times Cited: 20
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Xinping Cao, Xin Jin, Xiaomei Zhang, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 3, pp. 184-211
Open Access | Times Cited: 19
Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
Rebecca Kringel, Katrin Lamszus, Malte Mohme
Cells (2023) Vol. 12, Iss. 13, pp. 1770-1770
Open Access | Times Cited: 17
“Digital twins elucidate critical role of Tscm in clinical persistence of TCR-engineered cell therapy”
Louis R. Joslyn, Weize Huang, Dale Miles, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma
S. Yuan, Ying Chen, Huasheng Liu
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 7
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
CAR-T cell-derived exosomes: a new perspective for cancer therapy
Farnaz Sani, Shabnam Shojaei, Seyed Amirhossein Tabatabaei, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies
Xinyi Xiao, Yazhuo Wang, Zhengbang Zou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
Asmae Squalli Houssaini, Salma Lamrabet, Jean Paul Nshizirungu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 655-655
Open Access | Times Cited: 6
Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells
Jing Zhang, Jingjing Zhu, Genhui Zheng, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 21
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
Qiuqiang Chen, Lingeng Lu, Wenxue Ma
Cancers (2022) Vol. 14, Iss. 23, pp. 5983-5983
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top